Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04834869 · ClinicalTrials.gov registry record
COVID-19 Vaccines Safety Tracking (CoVaST)
A clinical trial of Adverse Reaction to Vaccine and COVID19 Vaccine, sponsored by Masaryk University.
- Recruiting
- Registry status
- 30,000
- Enrollment target
- 14
- Study locations
NCT04834869 is a study of Adverse Reaction to Vaccine and COVID19 Vaccine that is actively recruiting participants, run by Masaryk University. The registered enrollment target is 30,000 participants. The trial reports 14 study locations across 3 states.
The verdict
NCT04834869, a study of Adverse Reaction to Vaccine and COVID19 Vaccine, is actively recruiting participants, sponsored by Masaryk University.
- RECRUITING
- Registry status
- 30,000 participants
- Enrollment target
- 14
- Study locations
Study Summary
This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effect of each COVID-19 vaccine among healthcare workers (HCW), old adults over +65 (OA), and schoolteachers (ST); b) to evaluate the potential demographic and medical risk factors for side effects frequency and intensity; c) to evaluate the long-term consequences of COVID-19 vaccines. The secondary objectives include a) to evaluate the relative safety of COVID-19 vaccines compared to each other; b) to evaluate the impact of palliative drugs used by the recently vaccinated individuals on their short-term side effects resolution.
Conditions Studied
Interventions
- BIOLOGICAL BNT162b2
- BIOLOGICAL mRNA-1273
- BIOLOGICAL AZD1222
- BIOLOGICAL CoronaVac
- BIOLOGICAL Sinopharm
Study Locations (14)
Other
- University of Split - Split
- Masaryk University - Brno
- University of Tartu - Tartu
- Jimma University - Jimma
- Justus-Liebig University Giessen - Giessen
- University of Ghana - Accra
- Sinaloa's Pediatric Hospital - Culiacán
- Medical University of Silesia - Katowice
- Nursing School of Coimbra - Coimbra
- Irkutsk Scientific Center of Siberian Branch of Russian Academy of Sciences - Irkutsk
- University of Belgrade - Belgrade
- University of Ljubljana - Ljubljana
Pennsylvania
- American College of Physicians - Philadelphia
Ontario
- McMaster University - Hamilton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,000 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04834869
The ClinicalTrials.gov registry entry for NCT04834869 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masaryk University, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Adverse Reaction to Vaccine appearing as the primary indexed condition, and to 5 interventions - of which BNT162b2 is the first listed.
NCT04834869 reports 14 study locations spanning 3 distinct geographic areas - top geographies include Other, Pennsylvania, Ontario.
Frequently Asked Questions
What is clinical trial NCT04834869 about?
NCT04834869 is a clinical study titled "COVID-19 Vaccines Safety Tracking (CoVaST)". This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevalence of each local and systemic side effect of each COVID-19 vaccine among healthcare workers (HCW), old adults over +65 (OA), and schoolteach...
What is the current status of trial NCT04834869?
This trial is currently recruiting. The enrollment target is 30,000 participants. The study started on 2021-04-01. Estimated completion is 2026-12-31.
What conditions does trial NCT04834869 study?
This clinical trial studies the following conditions: Adverse Reaction to Vaccine, COVID19 Vaccine.
What interventions are being tested in trial NCT04834869?
The interventions under investigation include: BNT162b2 (BIOLOGICAL), mRNA-1273 (BIOLOGICAL), AZD1222 (BIOLOGICAL), CoronaVac (BIOLOGICAL), Sinopharm (BIOLOGICAL).
Who is sponsoring clinical trial NCT04834869?
This trial is sponsored by Masaryk University, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04834869 being conducted?
This trial has 14 study locations across Pennsylvania, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.